Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an EEG Diagnostic for Alzheimer's Disease: A Feasibility Study

NCT04954183 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04954183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04954183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an EEG Diagnostic for Alzheimer's Disease: A Feasibility Study
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
October 1, 2021
Completion date
July 24, 2025
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia with lewy bodies, mild cognitive impairment, normal control apoe e4 carriers and noncarriers